Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
In Vitro DiagnosticsArtificial IntelligenceDiagnostics AI

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739311

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1739311

Artificial Intelligence-based Medical Diagnostic Tools

PUBLISHED:
PAGES: 182 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5850
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 17550

Add to Cart

Description

Table of Contents

Global Artificial Intelligence-based Medical Diagnostic Tools Market to Reach US$4.8 Billion by 2030

The global market for Artificial Intelligence-based Medical Diagnostic Tools estimated at US$1.7 Billion in the year 2024, is expected to reach US$4.8 Billion by 2030, growing at a CAGR of 19.0% over the analysis period 2024-2030. AI Software, one of the segments analyzed in the report, is expected to record a 19.6% CAGR and reach US$2.3 Billion by the end of the analysis period. Growth in the AI Services segment is estimated at 17.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$445.7 Million While China is Forecast to Grow at 17.9% CAGR

The Artificial Intelligence-based Medical Diagnostic Tools market in the U.S. is estimated at US$445.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$739.3 Million by the year 2030 trailing a CAGR of 17.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 17.4% and 16.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 12.9% CAGR.

Global Artificial Intelligence-Based Medical Diagnostic Tools Market - Key Trends & Drivers Summarized

Why Are AI-Based Diagnostic Tools Reshaping the Medical Decision-Making Landscape?

Artificial Intelligence-based medical diagnostic tools are transforming clinical workflows and healthcare delivery by providing fast, accurate, and scalable diagnostic support across a broad spectrum of medical disciplines. These tools leverage machine learning (ML), deep learning, and natural language processing (NLP) to analyze diverse clinical data-including radiology images, pathology slides, genomic sequences, electronic health records (EHRs), and laboratory test results-to identify patterns, detect anomalies, and generate differential diagnoses with greater consistency and speed than traditional methods. As healthcare systems worldwide grapple with rising patient volumes, workforce shortages, and the demand for precision medicine, AI-powered diagnostics are emerging as indispensable aids for improving diagnostic accuracy and reducing variability in care.

Unlike conventional decision-support systems that rely on static rule sets, AI tools continuously learn and evolve by training on large datasets, often annotated by experts, to provide real-time, evidence-based insights. These systems are being integrated into radiology suites, pathology labs, primary care practices, and telehealth platforms to support early disease detection, triage, and risk stratification. From oncology and cardiology to ophthalmology and dermatology, AI is enabling faster identification of complex conditions-reducing diagnostic delays, enhancing clinical productivity, and facilitating timely interventions that improve patient outcomes.

How Are AI Algorithms Enhancing Diagnostic Performance Across Imaging, Genomics, and Multimodal Data?

AI-based diagnostic tools are revolutionizing medical imaging by interpreting CT scans, MRIs, X-rays, mammograms, and ultrasound images with high precision. Deep convolutional neural networks (CNNs) are widely used for image segmentation, feature extraction, and lesion classification, often outperforming human specialists in specific tasks such as lung nodule detection, breast cancer screening, and diabetic retinopathy grading. These tools not only accelerate image interpretation but also highlight abnormalities with heat maps and explainability features that improve clinical confidence and workflow integration.

In genomics, AI is helping decode complex genetic data for disease risk prediction, rare disease diagnosis, and therapy selection in oncology. Natural language processing algorithms extract clinically relevant data from unstructured EHRs, lab reports, and clinical notes to create comprehensive patient profiles and detect diagnostic signals that may be missed in manual review. Multimodal AI models, which combine imaging, lab values, genetic markers, and patient history, are gaining prominence for their ability to generate holistic diagnostic insights and personalized treatment recommendations. These advances are pushing diagnostic tools beyond single-modality accuracy toward integrative precision diagnostics that support value-based, data-driven care.

Where Is Market Demand Accelerating and Which Clinical Segments Are Leading AI Diagnostic Adoption?

Demand for AI-based medical diagnostic tools is expanding rapidly across the U.S., Europe, and Asia-Pacific, driven by rising healthcare digitization, policy support for AI integration, and growing acceptance among clinicians. North America leads in adoption, supported by advanced health IT infrastructure, favorable reimbursement pilots, and an active ecosystem of medtech startups, academic institutions, and regulatory pathways (e.g., FDA’s AI/ML-based Software as a Medical Device framework). Europe is witnessing increased uptake through national health systems and EU-backed innovation programs. In Asia-Pacific, countries like China, South Korea, Japan, and India are accelerating deployment in hospitals and diagnostics labs, aided by public-private partnerships and AI-centric healthcare reforms.

Radiology remains the most active application area, where AI tools are addressing diagnostic backlogs and enabling teleradiology. Pathology and oncology are key growth segments, with AI aiding in tumor classification, mutation profiling, and biopsy analysis. Cardiology is leveraging AI for ECG interpretation, heart failure risk prediction, and imaging-based structural assessments. Ophthalmology and dermatology are deploying AI for diabetic eye screening and skin lesion analysis, often via mobile or cloud-based solutions. Emerging applications in infectious disease detection (e.g., COVID-19, TB) and point-of-care diagnostics are expanding reach into underserved and rural healthcare environments, where clinician shortages persist.

What Is Driving the Global Growth of AI-Based Medical Diagnostic Tools?

The growth in artificial intelligence-based medical diagnostic tools is driven by the convergence of healthcare digitalization, rising chronic disease burden, and the need for timely, cost-effective diagnostics at scale. A key driver is the increasing availability of structured and unstructured clinical data, coupled with advances in cloud computing, edge AI, and federated learning, which allow for secure, scalable deployment across care settings. These tools reduce diagnostic errors, improve clinical throughput, and enable earlier interventions-aligning with global goals of achieving better outcomes while reducing healthcare costs.

Regulatory bodies are evolving to support AI integration through adaptive approval pathways, real-world validation requirements, and post-market performance monitoring. AI tools are also gaining traction as clinical decision-support systems (CDSS) integrated within EHRs, PACS, and telehealth platforms-enhancing their usability and clinical adoption. As medtech companies, payers, and provider networks increasingly invest in AI diagnostics for population health, personalized medicine, and remote care, a pivotal question surfaces: Can AI-based diagnostic tools achieve widespread clinical trust, interoperability, and equitable access to redefine global standards for timely and precise medical diagnosis?

SCOPE OF STUDY:

The report analyzes the Artificial Intelligence-based Medical Diagnostic Tools market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Component (Software, Services, Hardware, Memory, Other Components); Application (Radiology, Cardiology, Neurology, Oncology, Other Applications); Vertical (Hospitals, Diagnostic Laboratories, Other Verticals)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Ada Health
  • Aidmed
  • Aidoc
  • Aiforia
  • AliveCor
  • Bay Labs
  • Behold.ai
  • Butterfly Network
  • Caption Health
  • Cardiologs
  • Cleerly
  • DeepMind Health
  • Digital Diagnostics
  • Eko Health
  • Enlitic
  • GE Healthcare
  • Ibex Medical Analytics
  • InferVision
  • Lunit
  • Medtronic

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA <> CHINA <> MEXICO <> CANADA <> EU <> JAPAN <> INDIA <> 176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

COMPLIMENTARY PREVIEW

Contact your sales agent to request an online 300+ page complimentary preview of this research project. Our preview will present full stack sources, and validated domain expert data transcripts. Deep dive into our interactive data-driven online platform.

Show more
Product Code: MCP33471

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Artificial Intelligence-based Medical Diagnostic Tools - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Early Detection Capabilities Position AI Diagnostic Tools as Frontline Screening Technologies
    • Integration With Imaging Modalities Enhances Diagnostic Accuracy in Radiology and Pathology
    • AI-Based Tools Support Faster Triage and Clinical Decision-Making in Overburdened Healthcare Systems
    • Explainable AI Models Increase Physician Trust in Medical Diagnostic Algorithms
    • Expansion in Cloud-Based Platforms Drives Scalability of AI Diagnostic Tools Across Hospitals
    • Multi-Disease Screening Algorithms Enable Versatile Deployment of AI Medical Diagnostics
    • AI Integration Reduces Diagnostic Error Rates in Complex and Rare Disease Cases
    • Regulatory Approvals for AI Diagnostic Tools Expand Clinical Use in Primary and Secondary Care
    • Workflow Integration With EHRs and PACS Systems Boosts Adoption of AI Diagnostic Technologies
    • Consumer-Facing AI Tools Bridge Gaps in Access to Specialist Diagnostics
    • Telehealth Platforms Leverage AI Diagnostics for Real-Time Remote Evaluation
    • Cross-Specialty Application Potential Strengthens the Long-Term Value of AI-Based Diagnostic Tools
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Intelligence-based Medical Diagnostic Tools Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Memory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Memory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Components by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Components by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Radiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Radiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Cardiology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Cardiology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Other Verticals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Other Verticals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 31: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • CANADA
    • TABLE 36: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • JAPAN
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 42: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Japan 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • CHINA
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 48: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 52: China Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: China 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • EUROPE
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 54: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 55: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 58: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 60: Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • FRANCE
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 64: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 65: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 66: France Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: France 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • GERMANY
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 70: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 72: Germany Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Germany 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 76: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 78: Italy Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: Italy 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • UNITED KINGDOM
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 82: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 84: UK Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: UK 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 88: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 90: Rest of Europe Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Rest of Europe 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Intelligence-based Medical Diagnostic Tools Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 94: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 96: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Asia-Pacific 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 98: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Component - Software, Services, Hardware, Memory and Other Components - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Component - Percentage Breakdown of Value Sales for Software, Services, Hardware, Memory and Other Components for the Years 2025 & 2030
    • TABLE 100: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Application - Other Applications, Radiology, Cardiology, Neurology and Oncology - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Application - Percentage Breakdown of Value Sales for Other Applications, Radiology, Cardiology, Neurology and Oncology for the Years 2025 & 2030
    • TABLE 102: Rest of World Recent Past, Current & Future Analysis for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Hospitals, Diagnostic Laboratories and Other Verticals - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: Rest of World 6-Year Perspective for Artificial Intelligence-based Medical Diagnostic Tools by Vertical - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories and Other Verticals for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!